Diane Von Ah1, Adele Crouch, Elizabeth Arthur, Yesol Yang, Timiya Nolan. 1. Author Affiliations: College of Nursing, The Ohio State University, Columbus (Drs Von Ah and Nolan); NewCourtland Center for Transitions and Health, University of Pennsylvania School of Nursing, Philadelphia (Dr Crouch); and The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus (Drs Arthur and Yang).
Abstract
BACKGROUND: Breast cancer survivors (BCSs) may have a greater risk for cardiovascular disease (congestive heart failure and hypertension), which in turn, can affect cognitive dysfunction, a frequent, bothersome, and potentially debilitating symptom. OBJECTIVE: The purpose of this study was to examine the relationship of cardiovascular disease on cognitive function in BCSs. METHODS: Baseline data from a double-blind randomized controlled trial for cognitive training of BCSs were examined. Early-stage BCS (stages I-IIIA) who were 21 years or older, completed adjuvant therapy (≥6 months), and reported cognitive concerns completed questionnaires and a brief neuropsychological assessment, including tests of memory, attention and working memory, speed of processing, and verbal fluency. Descriptive statistics, Pearson correlation coefficient, and separate linear regression models for each cognitive domain were conducted. RESULTS: Forty-seven BCSs, who were on average 57.3 (SD, 8.1) years old, were 58% White, and had some college education (75%), completed the study. Furthermore, 44.7% of the BCS had cardiovascular disease (congestive heart failure or hypertension). In linear regression models, cardiovascular disease was significantly related to immediate and delayed memory and attention and working memory (P < .01-.05). CONCLUSION: Breast cancer survivors who have cardiovascular disease may also be at a greater risk for cognitive dysfunction post treatment. Results from this study inform both clinical practice and future research, specifically by examining the intersection between cancer, cardiovascular disease (cardiotoxicity), and cognition. IMPLICATIONS FOR PRACTICE: Nurses should be aware that BCSs with co-occurring cardiovascular disease are at a higher risk for cognitive dysfunction and work within the multidisciplinary team to optimize BCS health and function.
BACKGROUND: Breast cancer survivors (BCSs) may have a greater risk for cardiovascular disease (congestive heart failure and hypertension), which in turn, can affect cognitive dysfunction, a frequent, bothersome, and potentially debilitating symptom. OBJECTIVE: The purpose of this study was to examine the relationship of cardiovascular disease on cognitive function in BCSs. METHODS: Baseline data from a double-blind randomized controlled trial for cognitive training of BCSs were examined. Early-stage BCS (stages I-IIIA) who were 21 years or older, completed adjuvant therapy (≥6 months), and reported cognitive concerns completed questionnaires and a brief neuropsychological assessment, including tests of memory, attention and working memory, speed of processing, and verbal fluency. Descriptive statistics, Pearson correlation coefficient, and separate linear regression models for each cognitive domain were conducted. RESULTS: Forty-seven BCSs, who were on average 57.3 (SD, 8.1) years old, were 58% White, and had some college education (75%), completed the study. Furthermore, 44.7% of the BCS had cardiovascular disease (congestive heart failure or hypertension). In linear regression models, cardiovascular disease was significantly related to immediate and delayed memory and attention and working memory (P < .01-.05). CONCLUSION: Breast cancer survivors who have cardiovascular disease may also be at a greater risk for cognitive dysfunction post treatment. Results from this study inform both clinical practice and future research, specifically by examining the intersection between cancer, cardiovascular disease (cardiotoxicity), and cognition. IMPLICATIONS FOR PRACTICE: Nurses should be aware that BCSs with co-occurring cardiovascular disease are at a higher risk for cognitive dysfunction and work within the multidisciplinary team to optimize BCS health and function.
Authors: Kathryn E Weaver; Randi E Foraker; Catherine M Alfano; Julia H Rowland; Neeraj K Arora; Keith M Bellizzi; Ann S Hamilton; Ingrid Oakley-Girvan; Gretchen Keel; Noreen M Aziz Journal: J Cancer Surviv Date: 2013-02-16 Impact factor: 4.442
Authors: Daniel H Chen; Sara Tyebally; Michael Malloupas; Rebecca Roylance; Emma Spurrell; Fharat Raja; Arjun K Ghosh Journal: Curr Cardiol Rep Date: 2021-01-26 Impact factor: 2.931
Authors: Aicha B C Dijkshoorn; Haike E van Stralen; Maurits Sloots; Sanne B Schagen; Johanna M A Visser-Meily; Vera P M Schepers Journal: Psychooncology Date: 2021-02-02 Impact factor: 3.894
Authors: Annabelle Santos Volgman; C Noel Bairey Merz; Neelum T Aggarwal; Vera Bittner; T Jared Bunch; Philip B Gorelick; Pauline Maki; Hena N Patel; Athena Poppas; Jeremy Ruskin; Andrea M Russo; Shari R Waldstein; Nanette K Wenger; Kristine Yaffe; Carl J Pepine Journal: J Am Heart Assoc Date: 2019-09-24 Impact factor: 5.501
Authors: Adele Crouch; Victoria L Champion; Frederick W Unverzagt; Susan J Pressler; Lesa Huber; Lyndsi R Moser; David Cella; Diane Von Ah Journal: J Geriatr Oncol Date: 2021-07-08 Impact factor: 3.599
Authors: Erin J Aiello Bowles; Robert Wellman; Heather Spencer Feigelson; Adedayo A Onitilo; Andrew N Freedman; Thomas Delate; Larry A Allen; Larissa Nekhlyudov; Katrina A B Goddard; Robert L Davis; Laurel A Habel; Marianne Ulcickas Yood; Catherine McCarty; David J Magid; Edward H Wagner Journal: J Natl Cancer Inst Date: 2012-09-05 Impact factor: 13.506
Authors: V Jenkins; V Shilling; G Deutsch; D Bloomfield; R Morris; S Allan; H Bishop; N Hodson; S Mitra; G Sadler; E Shah; R Stein; S Whitehead; J Winstanley Journal: Br J Cancer Date: 2006-03-27 Impact factor: 7.640